[Therapy of juvenile chronic arthritis with sulfasalazine].
Sulfasalazine was used as second line agent in 15 children with different forms of rheumatoid arthritis. In 9 cases amelioration could be achieved with respect to clinical symptoms as well as laboratory parameters. Thus, sulfasalazine can be recommended as basic medication also in juvenile rheumatoid arthritis.
D000293:Adolescent; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use*
D012460:Sulfasalazine
Die Therapie der juvenilen chronischen Arthritis mit Sulfasalazin.